[{"Assets_0_Q1_USD":1422914000.0,"CommonStockSharesOutstanding_0_Q1_shares":51034172.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-149934000.0,"NetIncomeLoss_1_Q1_USD":-163406000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":48491834.0,"StockholdersEquity_0_Q1_USD":1319534000.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190502"}]